anonymous
Guest
anonymous
Guest
Greene has REALLY gotta go. Complete disaster.
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
https://finance.yahoo.com/news/disappointing-parkinsons-data-sage-therapeutics-131900320.html
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
https://finance.yahoo.com/news/disappointing-parkinsons-data-sage-therapeutics-131900320.html